![Potential Future Use, Costs, and Value of Poliovirus Vaccines - Thompson - 2021 - Risk Analysis - Wiley Online Library Potential Future Use, Costs, and Value of Poliovirus Vaccines - Thompson - 2021 - Risk Analysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2b7b0f1d-7163-4371-9a92-e395ea351db1/risa13557-fig-0001-m.jpg)
Potential Future Use, Costs, and Value of Poliovirus Vaccines - Thompson - 2021 - Risk Analysis - Wiley Online Library
Combined Immunization of Infants with Oral and Inactivated Poliovirus Vaccines: Results of a Randomized Trial in The Gambia, Oma
![Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c090e0f6fa9d816bbddd2656dafd8645ddba3bc/6-Table3-1.png)
Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar
![Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6c090e0f6fa9d816bbddd2656dafd8645ddba3bc/4-Table1-1.png)
Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? | Semantic Scholar
![Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial - The Lancet Infectious Diseases Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e0686311-5a3c-421f-a67a-9f2ff737ca5e/gr1_lrg.jpg)
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial - The Lancet Infectious Diseases
![PDF] Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. | Semantic Scholar PDF] Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/27701a7fa20c5b25ea4c98e45f9c39b07769d457/5-Table1-1.png)
PDF] Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. | Semantic Scholar
![Ministry of Health on Twitter: "Double protection against polio with IPV + OPV. #SwasthaBharat https://t.co/0u3CHidz28" / Twitter Ministry of Health on Twitter: "Double protection against polio with IPV + OPV. #SwasthaBharat https://t.co/0u3CHidz28" / Twitter](https://pbs.twimg.com/media/CzsO4tgVQAAfgGv.jpg)